Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD), obesity and type 2 diabetes mellitus (T2DM) are interconnected global epidemics that frequently coexist and mutually reinforce disease progression and adverse clinical outcomes. MASLD, the most ... ...
